BYZOR Trademark

Trademark Overview

On Monday, July 27, 2009, a trademark application was filed for BYZOR with the United States Patent and Trademark Office. The USPTO has given the BYZOR trademark a serial number of 77790618. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2013. This trademark is owned by Glaxo Group Limited. The BYZOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

General Information

Serial Number77790618
Word MarkBYZOR
Filing DateMonday, July 27, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 30, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, May 6, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 6, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, September 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 21, 2012EXTENSION 5 GRANTED
Wednesday, September 19, 2012EXTENSION 5 FILED
Wednesday, September 19, 2012TEAS EXTENSION RECEIVED
Saturday, April 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2012EXTENSION 4 GRANTED
Tuesday, April 3, 2012EXTENSION 4 FILED
Tuesday, April 3, 2012TEAS EXTENSION RECEIVED
Friday, October 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2011EXTENSION 3 GRANTED
Tuesday, October 4, 2011EXTENSION 3 FILED
Tuesday, October 4, 2011TEAS EXTENSION RECEIVED
Tuesday, March 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2011EXTENSION 2 GRANTED
Tuesday, March 15, 2011EXTENSION 2 FILED
Tuesday, March 15, 2011TEAS EXTENSION RECEIVED
Wednesday, October 6, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2010EXTENSION 1 GRANTED
Tuesday, September 14, 2010EXTENSION 1 FILED
Tuesday, October 5, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 14, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2010PUBLISHED FOR OPPOSITION
Friday, December 4, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 4, 2009ASSIGNED TO LIE
Tuesday, November 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 21, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, October 21, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 21, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, October 21, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, October 12, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 12, 2009NON-FINAL ACTION E-MAILED
Monday, October 12, 2009NON-FINAL ACTION WRITTEN
Wednesday, October 7, 2009ASSIGNED TO EXAMINER
Thursday, July 30, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 30, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

byzor pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic